Assessments for the 𝘐𝘯 𝘝𝘪𝘷𝘰 Tolerability and Efficacy of a JAK1-siRNA Being Developed for the Highly Targeted, Infrequent, and Efficacious Treatment of Inflammatory Skin Diseases Using Various Application Techniques